PL1636348T3 - Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych - Google Patents

Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych

Info

Publication number
PL1636348T3
PL1636348T3 PL04737673T PL04737673T PL1636348T3 PL 1636348 T3 PL1636348 T3 PL 1636348T3 PL 04737673 T PL04737673 T PL 04737673T PL 04737673 T PL04737673 T PL 04737673T PL 1636348 T3 PL1636348 T3 PL 1636348T3
Authority
PL
Poland
Prior art keywords
cells
exocrine pancreatic
islet beta
pancreatic cells
generating islet
Prior art date
Application number
PL04737673T
Other languages
English (en)
Inventor
Luc Bouwens
Luc Baeyens
Original Assignee
Vrije Univ Brussel Vub
Opus Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vrije Univ Brussel Vub, Opus Nv filed Critical Vrije Univ Brussel Vub
Publication of PL1636348T3 publication Critical patent/PL1636348T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/235Leukemia inhibitory factor [LIF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/22Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from pancreatic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04737673T 2003-06-20 2004-06-21 Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych PL1636348T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03447164 2003-06-20
PCT/BE2004/000089 WO2004113512A2 (en) 2003-06-20 2004-06-21 Method of generating islet beta-cells from exocrine pancreatic cells
EP04737673A EP1636348B1 (en) 2003-06-20 2004-06-21 Method of generating islet beta-cells from exocrine pancreatic cells

Publications (1)

Publication Number Publication Date
PL1636348T3 true PL1636348T3 (pl) 2010-01-29

Family

ID=33522524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04737673T PL1636348T3 (pl) 2003-06-20 2004-06-21 Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych

Country Status (13)

Country Link
US (1) US7604991B2 (pl)
EP (1) EP1636348B1 (pl)
JP (1) JP2007520194A (pl)
AT (1) ATE437941T1 (pl)
CA (1) CA2527626A1 (pl)
CY (1) CY1109474T1 (pl)
DE (1) DE602004022292D1 (pl)
DK (1) DK1636348T3 (pl)
ES (1) ES2330438T3 (pl)
PL (1) PL1636348T3 (pl)
PT (1) PT1636348E (pl)
SI (1) SI1636348T1 (pl)
WO (1) WO2004113512A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103637A1 (en) * 2008-02-22 2009-08-27 Vrije Universiteit Brussel Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells
EP2864473B1 (en) 2012-06-26 2019-08-21 Seraxis, Inc. Stem cells and pancreatic cells useful for the treatment of insulin-dependent diabetes mellitus
US9988605B2 (en) * 2013-12-11 2018-06-05 Korea Advanced Institute Of Science And Technology Method for preparing endocrine aggregate of insulin-producing beta cells from human pluripotent stem cells
US11466255B2 (en) 2015-05-01 2022-10-11 University Of Miami Methods and compositions for converting non-endocrine pancreatic tissue into insulin-producing cells
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739771B2 (en) * 1995-10-25 2001-10-18 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of langerhans and in vivo uses thereof
ATE445006T1 (de) * 1998-08-10 2009-10-15 Us Gov Health & Human Serv Differenzierung von nicht-insulin in insulin- produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
KR19990014353A (ko) * 1998-10-17 1999-02-25 윤태욱 췌도의 대량 배양증식방법
US6815203B1 (en) * 1999-06-23 2004-11-09 Joslin Diabetes Center, Inc. Methods of making pancreatic islet cells
MXPA02004268A (es) * 1999-10-29 2003-01-28 Univ Mcgill Medio para preparar celulas dediferenciadas.
US6610535B1 (en) * 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
ES2299417T3 (es) 2000-04-12 2008-06-01 Beta-Cell N.V. Metodo para producir preparaciones de celulas endocrinas pancreaticas madura e inmaduras, preparacion de las celulas y su utilizacion para el tratamiento de la diabetes mellitus.
FR2814752A1 (fr) * 2000-10-02 2002-04-05 Chru Lille Procede d'obtention in vitro de cellules insulino- secretrices de mammifere et leurs utilisations
WO2003102134A2 (en) * 2002-05-28 2003-12-11 Becton, Dickinson And Company Pancreatic acinar cells into insulin producing cells

Also Published As

Publication number Publication date
ES2330438T3 (es) 2009-12-10
US20070292388A1 (en) 2007-12-20
PT1636348E (pt) 2009-10-21
US7604991B2 (en) 2009-10-20
CY1109474T1 (el) 2014-08-13
DK1636348T3 (da) 2009-11-23
EP1636348A2 (en) 2006-03-22
CA2527626A1 (en) 2004-12-29
SI1636348T1 (sl) 2010-01-29
ATE437941T1 (de) 2009-08-15
WO2004113512A2 (en) 2004-12-29
EP1636348B1 (en) 2009-07-29
WO2004113512A3 (en) 2005-03-31
JP2007520194A (ja) 2007-07-26
DE602004022292D1 (de) 2009-09-10

Similar Documents

Publication Publication Date Title
WO2005086860A3 (en) Methods for generating insulin-producing cells
GB2442406A (en) Mesoderm and definitive endoderm cell populations
CY1109474T1 (el) Μεθοδος δημιουργιας β-κυτταρων νησιδιων απο ενδοκρινη παγκρεατικα κυτταρα
GEAP202315908A (en) Polyheterocyclic modulators of sting (stimulator of interferon genes)
BRPI0819609A2 (pt) Diferenciação de células-tronco embrionárias de ser humano
CA2470539A1 (en) Islet cells from human embryonic stem cells
TW200943454A (en) Apparatus for treating substrate
MX2009013706A (es) Celulas multipotentes/pluripotentes y metodos relacionados.
WO2009050742A8 (en) Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
SG11201809400UA (en) Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method therefor
NZ711958A (en) Compositions and methods of using islet neogenesis peptides and analogs thereof
WO2002029010A3 (fr) Procede d'obtention in vitro de cellules insulino-secretrices de mammifere et leurs utilisations
WO2003072728A3 (en) Cellular trans-differentiation
WO2002074045A3 (en) Production of pancreatic islet cells and delivery of insulin
WO2005094353A3 (en) Methods for production of regulatory t cells and uses thereof
MX2010012730A (es) Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina.
WO2009062260A8 (en) Therapy for multiple sclerosis
EP4257143A3 (en) Methods and compositions for treatment of type 1 diabetes using fibroblasts as facilitators of islet engraftment
TW200602044A (en) Compounds
IL145674A (en) Use of heregulin in the preparation of a medicament for treating pancreatic dysfunction
TW200630348A (en) Tadalafil crystal forms and processes for preparing them
IL164250A0 (en) Chimeric pancreas
IL191782A0 (en) Method for generating dendritic cells employing decreased temperature
Efrat Generation of surrogate beta cells from tissue stem cells
TW200630410A (en) Branched polycarbonates